FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Mankind Pharma IPO and Radiant Cash Management IPO.
Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Radiant Cash Management IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Mankind Pharma IPO | Radiant Cash Management IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited |
Iifl Securities Ltd Motilal Oswal Investment Advisors Limited Yes Securities (India) Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Radiant Cash Management IPO is up to ₹256.64 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Radiant Cash Management IPO is ₹94.00 per share.
Mankind Pharma IPO | Radiant Cash Management IPO | |
---|---|---|
Face Value | ₹1 per share | ₹1 per share |
Issue Price (Lower) | ₹1,026.00 per share | ₹94.00 per share |
Issue Price (Upper) | ₹1,080.00 per share | ₹99.00 per share |
Issue Price (Final) | ₹1,080.00 per share | ₹94.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 13 shares | 150 shares |
Fresh Issue Size | 54,54,546 shares | |
Fresh Issue Size (Amount) | up to ₹54.00 Cr | |
OFS Issue Size | 4,00,58,844 shares | 2,12,22,431 shares |
OFS Issue Size (Amount) | up to ₹4,326.36 Cr | up to ₹202.64 Cr |
Issue Size Total | 4,00,58,844 shares | 2,66,76,977 shares |
Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹256.64 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Radiant Cash Management IPO opens on Dec 23, 2022. The closing date of Mankind Pharma IPO and Radiant Cash Management IPO is Apr 27, 2023, and Dec 27, 2022, respectively.
Mankind Pharma IPO | Radiant Cash Management IPO | |
---|---|---|
Anchor Bid Date | Apr 24, 2023 | Dec 22, 2022 |
Issue Open | Apr 25, 2023 | Dec 23, 2022 |
Issue Close | Apr 27, 2023 | Dec 27, 2022 |
Basis Of Allotment (Tentative) | May 03, 2023 | Dec 30, 2022 |
Initiation of Refunds (Tentative) | May 04, 2023 | Jan 02, 2023 |
Credit of Share (Tentative) | May 05, 2023 | Jan 03, 2023 |
Listing date (Tentative) | May 09, 2023 | Jan 04, 2023 |
Anchor Lockin End date 1 | Jun 02, 2023 | Jan 29, 2023 |
Anchor Lockin End date 2 | Aug 01, 2023 | Mar 30, 2023 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Radiant Cash Management IPO P/E ratio of 17.34.
Mankind Pharma IPO | Radiant Cash Management IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 79.00% | 66.39% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 76.50% | 53.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 32.5 | 17.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹43263.60 Cr. | ₹1062.41 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.60%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.10%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹33.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.70%% |
In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Radiant Cash Management IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 78,37,121 shares in Radiant Cash Management IPO.
Mankind Pharma IPO | Radiant Cash Management IPO | |
---|---|---|
Anchor Investor Reserveration | 1,20,17,652 shares | |
Market Maker Reserveration | ||
QIB | 80,11,769 shares | 78,37,121 shares |
NII | 60,08,827 shares | 58,77,841 shares |
RII | 1,40,20,596 shares | 1,37,14,963 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 2,80,41,192 shares | 2,74,29,925 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Radiant Cash Management IPO subscribed 0.53x.
Mankind Pharma IPO | Radiant Cash Management IPO | |
---|---|---|
QIB (times) | 49.16x | 1.01x |
NII (times) | 3.80x | 0.66x |
Big NII (times) | 4.99x | 0.94x |
Small NII (times) | 1.41x | 0.09x |
RII (times) | 0.92x | 0.21x |
Employee (times) | ||
Other (times) | ||
Total (times) | 15.32x | 0.53x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|